RMMS Expands Life Science Team with Addition of Kevin Warner

September 9, 2021 | Announcements

09/09/2021 RMMS is pleased to welcome Kevin Warner to the firm as a partner. Prior to joining RMMS, Kevin was a partner at Winston & Strawn LLP where he specialized in life sciences patent and intellectual property litigation.

Kevin has extensive Hatch-Waxman counseling and trial experience, as well as experience in the biosimilar arena. His cases have involved a wide range of pharmaceutical products, medical devices and related technology areas, as well as antitrust counseling. Outside the pharmaceutical arts, Kevin has represented numerous companies in complex patent litigations, commercial litigations, government investigations and related corporate counseling. He has nearly 20 years of experience trying cases before juries, judges and private tribunals in forums across the country.

Kevin’s breadth of knowledge and experience will help RMMS continue to provide its clients with the top-level service for which the firm is known.

About RMMS Headquartered in Chicago,RMMS is a full-service litigation and intellectual property law firm with over 30 attorneys devoted exclusively to the life sciences industry, including specialty practice in the field of patent and regulatory counseling and litigation under theHatch-Waxman Act, the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), and the Biologics Price Competition and Innovation Act (BPCIA).